Fernando Martín-Delgado Santos

Fernando Martín-Delgado Santos, listed as board member, appears in our data through filings on Pharma Mar, S.A. shares, published by CNMV. We count 4 filings; the first trade dates from 26 March 2025 and the latest from 14 October 2026.

Every open-market trade on record is a purchase: 4 purchases worth €54k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 1 purchase and no sales.

The median purchase comes to €8,169. As a share of market capitalisation, the median purchase stands at 0.0005%, based on 4 purchases. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +14.0%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 14 October 2026, the filings show an open-market purchase worth €399 in Pharma Mar, S.A. Between a trade and the moment it shows up on CNMV, the median delay is 2 days. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from CNMV. Past trades are no guide to future returns.